Salford Royal NHS Foundation Trust operated Salford Royal Hospital in Greater Manchester until 2017. Its chief executive is Raj Jain. In December 2017 it was announced that the Trust was to form a new healthcare organisation by combining with Pennine Acute Hospitals NHS Trust.

During the past decade, Hope Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hope Hospital" #1 sponsor was "Genzyme, a Sanofi Company" with 4 trials, followed by "Abbott" with 2 trials sponsored, "Aberdeen Royal Infirmary" with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Alizyme" with 1 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hope Hospital" #1 collaborator was "Action Medical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hope Hospital" are "Prostate Cancer" (5 trials), "Fabry Disease" (3 trials), "Anemia" (2 trials), "Sexual Dysfunction" (2 trials) and "Acute Coronary Syndromes" (1 trials). Many other conditions were trialed in "Hope Hospital" in a lesser frequency.

Most popular intervention types in "Hope Hospital" are "Drug" (18 trials), "Procedure" (5 trials), "Biological" (4 trials), "Other" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atrasentan" (2 trials), "Fabrazyme (agalsidase beta)" (2 trials), "adjuvant therapy" (2 trials) and "quality-of-life assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hope Hospital" are 19 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Hope Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Hope Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hope Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".